A lipid panel is a single blood test that measures the fats circulating in your blood — total cholesterol, LDL and HDL cholesterol, and triglycerides — to estimate your risk of heart attack and stroke. Extended panels add apolipoprotein B, apolipoprotein A1 and lipoprotein(a), which count the actual particles that carry that cholesterol. Together the numbers describe how much artery-clogging cholesterol is in circulation and how well your body clears it.
What the lipid panel measures
Cholesterol does not dissolve in blood, so it travels packaged inside lipoprotein particles. The panel reads those particles from two angles: the cholesterol they carry (total, LDL and HDL) and, on extended panels, the particles themselves (ApoB and ApoA1). LDL delivers cholesterol to tissues and, in excess, into artery walls; HDL carries it back to the liver. Triglycerides are a separate fat that tracks with diet, alcohol and metabolic health. Reading these together — rather than fixating on one figure — is what turns a lipid panel into a cardiovascular-risk estimate, and MedlinePlus frames the panel as a routine measure of heart-disease risk. Most labs also report non-HDL cholesterol — total cholesterol minus HDL — as a single figure that captures every atherogenic particle at once, a reliable read even on a non-fasting sample.
Which tests are included
- Total Cholesterol — all the cholesterol in the blood; a rough headline number.
- LDL Cholesterol — the main artery-clogging fraction and the primary treatment target.
- HDL Cholesterol — the “protective” cholesterol returned to the liver; low HDL adds risk.
- Triglycerides — circulating fat tied to diet, alcohol and insulin resistance.
- Apolipoprotein B (ApoB) — counts every atherogenic particle; often a truer risk marker than LDL alone.
- Apolipoprotein A1 (ApoA1) — the main protein of HDL; reflects protective capacity.
- Lipoprotein(a) — an inherited, independent risk particle measured once in a lifetime.
- Cholesterol Ratio (Atherogenic Index) — the total-to-HDL ratio that summarises the balance.
Values are reported in mg/dL in the US and mmol/L in most of the world; the unit converter switches between them.
When doctors order it
Routine cardiovascular screening is the commonest reason — most guidelines start in early adulthood and repeat through midlife. A panel is also ordered when you have risk factors such as high blood pressure, diabetes, obesity, smoking or a family history of early heart disease; to investigate physical signs such as fatty skin deposits (xanthomas); and to start or monitor cholesterol-lowering treatment such as statins. A markedly high triglyceride result is flagged separately, because very high levels carry their own risk of pancreatitis and prompt faster action.
How to prepare
For a standard panel you no longer need to fast — modern AHA/ACC and European guidance accept non-fasting samples for routine screening. Fasting for 9–12 hours is still requested when triglycerides are being tracked or already known to be high, because food raises them sharply. Keep alcohol moderate for a couple of days beforehand, and tell your doctor about your medicines and any pregnancy, both of which shift the numbers. Lipoprotein(a) is largely genetic and needs no fasting.
How to read the results together
The value of the panel is in the combinations, not any single number:
- High LDL with high ApoB confirms a heavy burden of atherogenic particles. When ApoB is high but LDL looks only borderline — often alongside high triglycerides — ApoB reveals risk the LDL number understates.
- High triglycerides with low HDL is the classic signature of insulin resistance and metabolic syndrome, and it usually raises non-HDL cholesterol even when LDL seems controlled.
- A high total-to-HDL ratio, or a high atherogenic index, captures the balance between harmful and protective cholesterol in a single figure.
- A raised lipoprotein(a) flags inherited risk that sits on top of everything else and does not move with diet.
No single value diagnoses heart disease; doctors fold these patterns into an overall risk score with your age, blood pressure and smoking.
When to retest
For a normal result at low risk, most guidelines suggest rechecking every 4–6 years. After starting or changing a statin, lipids are usually repeated 4–12 weeks later to confirm the response, then every 3–12 months once stable. Anyone with diabetes, known heart disease or a strong family history is monitored more closely — your doctor sets the interval.
